Veritable’s Sophiris Bio, Inc. SPHS Stock Holding History

Veritable’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,500	Closed	-$35K	–	972
2014 Q1	$35K	Hold	10,500	–	–	﹤0.01%	904
2013 Q4	$39K	Buy	+10,500	New	+$44.4K	﹤0.01%	932

Other funds holding SPHS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Veritable's SPHS Position: Q2 2014 in Review

Veritable sold out of Sophiris Bio, Inc. (SPHS) in Q2 2014, closing a stake of 10,500 shares — an estimated $35K sold.

Veritable first reported a position in SPHS in Q4 2013 and held it in 2 quarters. The position peaked at $39K in Q4 2013. 18 funds tracked by Wall St. Rank hold SPHS as of Q2 2014.

Veritable reported no remaining Sophiris Bio, Inc. position as of Q2 2014 after selling out during the quarter.
Veritable sold 10,500 Sophiris Bio, Inc. shares in Q2 2014, an estimated $35K.
Veritable first reported a position in Sophiris Bio, Inc. in Q4 2013 and held it in 2 quarters.
Veritable's Sophiris Bio, Inc. position peaked at $39K in Q4 2013.
18 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2014.

Based on Veritable's 13F filing for Q2 2014, filed 14 Aug 2014.